ArticleSleep2025
Long-term welfare consequences of sleep apnea in 20-64-year-olds-influence of gender: a nationwide cohort study.
Article in Sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Annual Versus Patient-Initiated Follow-Up in Sleep Apnoea Care: A Quasi-Experimental Study.Journal of sleep research · 2026Article
- Rethinking Long-Term Follow-Up of CPAP Therapy in Obstructive Sleep Apnea: Toward Personalized and Integrated Care.Healthcare (Basel, Switzerland) · 2026Review
- Advances in the Diagnosis and Treatment of Obstructive Sleep Apnea in Women.Pulmonary therapy · 2026Review
- Multimorbidity patterns in elderly sleep disordered breathing patients.ERJ open research · 2026Article
- The gender gap in obstructive sleep apnea: unmasking the disproportionate costs on women.Sleep · 2025Article
- A Novel Approach to the Study of Pathophysiology in Patients with Obstructive Sleep Apnea Using the Iowa Oral Performance Instrument (IOPI).Journal of clinical medicine · 2025Article
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STUDY
objectivesObstructive sleep apnea (OSA) is associated with a significant welfare impact. Little information is available about long-term welfare consequences for women and men. Here we evaluated the long-term gender-associated welfare of patients with OSA.
methodsUsing data from the Danish National Patient Registry and other public databases, all patients aged 20-64 years with a diagnosis of OSA were included. They were compared with citizens matched by age, sex, marital status, and community location, in a ratio of 1:4. All health and social costs were included from public registries.
resultsA total of 55 783 men and 19 241 women with OSA were compared with 223 783 and 76 961 controls, respectively. As a group, people with OSA had significantly higher morbidity, mortality, health costs, transfer incomes, and sickness benefits, whereas their educational level and professional affiliation were lower, and patients retired earlier than their corresponding controls. These patterns could be identified as much as 15 years before diagnosis, with changes becoming more pronounced after diagnosis and management. There was a significant gender difference, whereby women had higher morbidity and mortality rates and social welfare social costs than men in all domains, before and after diagnosis. The total case patient net costs for men/women were 4217/8259 €/year before diagnosis and 8749/13 730 €/year after diagnosis.
conclusionsOSA is associated with a significant welfare costs (morbidity, mortality, healthcare cost, social impact). These effects are present years before diagnosis and increase thereafter. There are significant gender differences, whereby women tend to experience a significantly higher health and welfare costs than men before and after diagnosis. The study highlights a need to pay closer attention to OSA, particularly in women, in whom the disease is probably underdiagnosed.
Indexed as
Identifiers
40117453What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.